Are you Dr. Malluche?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 18 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
740 S Limestone
Lexington, KY 40536Phone+1 859-257-5116Fax+1 859-323-0232- Is this information wrong?
Summary
- Dr. Hartmut Malluche, MD is a nephrologist in Lexington, Kentucky. He is currently licensed to practice medicine in Kentucky, Florida, and California. He is affiliated with University of Kentucky Albert B. Chandler Hospital and is a Chief at Bone and Mineral Metabolism.
Education & Training
- Goethe University Frankfurt Medical FacultyClass of 1971
Certifications & Licensure
- CA State Medical License 1978 - 2026
- FL State Medical License 2014 - 2026
- KY State Medical License 1982 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
- Elected Member The American Society for Clinical Investigation, 1987
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Renal Osteodystrophy: A Fresh Approach Start of enrollment: 2009 Mar 01
- Effects of Zortress® + Tacrolimus vs. Standard Immunosuppression on Progression of Coronary Artery Calcifications and Bone Disease in de Novo Renal Transplant Recipients Start of enrollment: 2012 May 01
- Renal Osteodystrophy: An Individual Management Approach Start of enrollment: 2015 Jul 01
Publications & Presentations
PubMed
- .Williams, M., Halabi, C., Patel, H., Joseph, Z., McCommis, K., Weinheimer, C., Lima, F., Finck, B., Kovacs, A., Malluche, H., Hruska, K.> ;American Journal of Physiology. Renal Physiology. 2024 Feb 22
- Renal osteodystrophy: something old, something new, something needed.Valentin David, Isidro B Salusky, Hartmut Malluche, Thomas L Nickolas> ;Current Opinion in Nephrology and Hypertension. 2023 Nov 1
- 6 citationsTranscription factor HNF4α2 promotes osteogenesis and prevents bone abnormalities in mice with renal osteodystrophy.Marta Martinez-Calle, Guillaume Courbon, Bridget Hunt-Tobey, Connor Francis, Jadeah Spindler, Xueyan Wang, Luciene M Dos Reis, Carolina Sw Martins, Isidro B Salusky, H...> ;The Journal of Clinical Investigation. 2023 Jun 1
- Join now to see all
Press Mentions
- Quantitative Gadolinium-Free Cardiac Fibrosis Imaging in End Stage Renal Disease Patients Reveals A Longitudinal Correlation with Structural and Functional DeclineNovember 19th, 2018
Grant Support
- Renal Osteodystrophy: A Fresh ApproachNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2012
- Renal Bone DiseaseNational Center For Research Resources2004–2007
- Treatment Of Chronic HEP C With Peg-Intron And RebetronNational Center For Research Resources2005
- Renal Bone DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases1996–2004
- Endocrine Calcium/Phosphate Regulation, Brain Metabolism, And Alzheimer'SNational Center For Research Resources1996–1999
- Endocrine Calcium/Phosphate Regulation, Brain Metabolism, And Alzheimer'S DiseaseNational Institute On Aging1996–1997
- Bone Loss After OvariectomyNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1991–1994
- Bone Loss After Ovariectomy;Response To EstrogenNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1987–1988
- Aluminum In Bone And Muscle Abnormalities In UremiaNational Institute Of Diabetes And Digestive And Kidney Diseases1986–1987
- Bone Loss After Ovariectomy--Response To EstrogenNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1986
- Aluminum In Bone And Muscle Abnormalities In UremiaNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985
Hospital Affiliations
- University of Kentucky Albert B. Chandler HospitalLexington, Kentucky